β-ELEMENE - AN OVERVIEW

Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb successIn summary, though the medical result of tucidinostat to the procedure of PTCL has long been elucidated, further more mechanistic review and biomarker identification for patient stratification should be illustrated Later on.There ar